Lv1
48 积分 2022-11-07 加入
RYK is a GPNMB receptor that drives MASH
2天前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
2天前
已完结
Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
11天前
已完结
Advancing therapeutics in small-cell lung cancer
2个月前
已完结
GPT-4 assistance for improvement of physician performance on patient care tasks: a randomized controlled trial
2个月前
已完结
Advancing therapeutics in small-cell lung cancer
2个月前
已完结
EP.12.13 Gradually or Locally Progressed NSCLC Patients Benefit From Aumolertinib in Post-1L Dose-Escalation Treatment
4个月前
已关闭
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
4个月前
已完结
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
4个月前
已完结
EP.18.10 Phase II Study: Efficacy and Biomarker Exploration of Anlotinib Plus Penpulimab in ES-SCLC After Failure of Platinum-Based Chemotherapy
5个月前
已关闭
皖公网安备34019202002308
